Science
Multi-compartment blockade of resistant disease biology.
EMT-601 is designed to act across resistant tumor cells, activated fibroblasts, and angiogenic vasculature. The program pairs therapeutic targeting with PROXIMITY-Dx, a companion diagnostic approach intended to identify the co-localized disease state most relevant to EMT-601 engagement.
Function-blocking activity
Disrupts the fibronectin-matrix signaling axis associated with cancer stemness, drug resistance, and stromal stiffness.
Immune-effector design
Designed to engage macrophage biology in mesenchymal, drug-resistant tumor environments.
Stromal remodeling
Preclinical models support reduction of fibronectin and collagen-rich disease matrix while preserving a focus on safety and selectivity.
Public reference: Wu et al., Cancer Research Communications. 2025;5(1):195-208.